South & Central America Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals) and End User (Hospitals, Clinics, and Others)
The South & Central America parenteral nutrition market was valued at US$ 360.63 million in 2022 and is expected to reach US$ 597.42 million by 2030; it is estimated to record a CAGR of 6.5% from 2... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe South & Central America parenteral nutrition market was valued at US$ 360.63 million in 2022 and is expected to reach US$ 597.42 million by 2030; it is estimated to record a CAGR of 6.5% from 2022 to 2030.Improved Healthcare Infrastructure Fuels South & Central America Parenteral Nutrition Market With over 19,000 hospitals in the region, Latin America provides a wide range of healthcare options. As of 2023, there will be 6,642 more hospitals in Brazil than there are in the US. Investments in healthcare infrastructure and the expansion of healthcare facilities in the South & Central America region present opportunities for the development and distribution of parenteral nutrition products and services. Additionally, malnutrition affects 74% of severely ill hospitalized patients in Latin America. In order to fight patient malnutrition in Latin America and around the world, Fresenius Kabi is dedicated to advancing research and providing funds. Under the 'United for Clinical Nutrition' project, which aims to strengthen clinical research in Latin America, the company has provided research grants totaling US$ 106,630 (100,000) since 2018. In 2023, Healthcare practitioners applied for the third Parenteral Nutrition Research Grant Latin America to fund clinical nutrition research initiatives. The award is valid for two years. It seeks to support serious research in parenteral nutrition therapy, help solve the problem of malnourished critically ill patients in Latin America and provide funds to support additional research that will support appropriate parenteral nutrition. South & Central America Parenteral Nutrition Market Overview The incidence of neurological disorders has been correlated with the aging population in Brazil. According to the World Health Organization and the Brazilian Institute of Geography and Statistics, by 2040, the geriatric population in Brazil (aged above 60 years) will reach ~55 million. In the coming years, the rising geriatric population is anticipated to increase the incidence of chronic neurological disorders, which is likely to propel the demand for parenteral nutrition. Thus, the growing incidence of diabetes, cancer, and other chronic diseases drives the parenteral nutrition market in Brazil. This factor is likely to increase the demand for parenteral nutrition in treating patients. South & Central America Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million) South & Central America Parenteral Nutrition Market Segmentation The South & Central America parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the South & Central America parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022. By end user, the South & Central America parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022. Based on country, the South & Central America parenteral nutrition market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America parenteral nutrition market share in 2022. ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the South & Central America parenteral nutrition market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. South & Central America Parenteral Nutrition Market - Key Industry Dynamics 4.1 Market Drivers 4.1.1 Rise in Prevalence of Gastrointestinal Diseases 4.1.2 Surge in Cases of Malnutrition and Premature Births 4.2 Market Restraints 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems 4.3 Market Opportunities 4.3.1 Improved Healthcare Infrastructure in South & Central America 4.4 Future Trends 4.4.1 Innovation in Formulations of Nutrition Products 4.5 Impact Analysis 5. Parenteral Nutrition Market - South & Central America Market Analysis 5.1 Overview 5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030 6. South & Central America Parenteral Nutrition Market Analysis - by Nutrient Type 6.1 Overview 6.2 Single Dose Amino Acid Solution 6.2.1 Overview 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 6.3 Parenteral Lipid Emulsion 6.3.1 Overview 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 6.4 Carbohydrates 6.4.1 Overview 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 6.5 Trace Elements 6.5.1 Overview 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 6.6 Vitamins and Minerals 6.6.1 Overview 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 7. South & Central America Parenteral Nutrition Market Analysis - by End User 7.1 Overview 7.2 Hospitals 7.2.1 Overview 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 7.3 Clinics 7.3.1 Overview 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 7.4 Others 7.4.1 Overview 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 8. South & Central America Parenteral Nutrition Market - Country Analysis 8.1 South & Central America 8.1.1 South & Central America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country 8.1.1.1 Brazil: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 8.1.1.1.1 Overview 8.1.1.1.2 Brazil: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 8.1.1.1.3 Brazil: Parenteral Nutrition Market Breakdown, by Nutrient Type 8.1.1.1.4 Brazil: Parenteral Nutrition Market Breakdown, by End User 8.1.1.2 Argentina: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 8.1.1.2.1 Overview 8.1.1.2.2 Argentina: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 8.1.1.2.3 Argentina: Parenteral Nutrition Market Breakdown, by Nutrient Type 8.1.1.2.4 Argentina: Parenteral Nutrition Market Breakdown, by End User 8.1.1.3 Rest of South & Central America: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 8.1.1.3.1 Overview 8.1.1.3.2 Rest of South & Central America: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million) 8.1.1.3.3 Rest of South & Central America: Parenteral Nutrition Market Breakdown, by Nutrient Type 8.1.1.3.4 Rest of South & Central America: Parenteral Nutrition Market Breakdown, by End User 9. Industry Landscape 9.1 Overview 9.1.1 Overview 10. Company Profiles 10.1 ICU Medical Inc 10.1.1 Key Facts 10.1.2 Business Description 10.1.3 Products and Services 10.1.4 Financial Overview 10.1.5 SWOT Analysis 10.1.6 Key Developments 10.2 Grifols SA 10.2.1 Key Facts 10.2.2 Business Description 10.2.3 Products and Services 10.2.4 Financial Overview 10.2.5 SWOT Analysis 10.2.6 Key Developments 10.3 Pfizer Inc 10.3.1 Key Facts 10.3.2 Business Description 10.3.3 Products and Services 10.3.4 Financial Overview 10.3.5 SWOT Analysis 10.3.6 Key Developments 10.4 Otsuka Pharmaceuticals Co Ltd 10.4.1 Key Facts 10.4.2 Business Description 10.4.3 Products and Services 10.4.4 Financial Overview 10.4.5 SWOT Analysis 10.4.6 Key Developments 10.5 Baxter International Inc 10.5.1 Key Facts 10.5.2 Business Description 10.5.3 Products and Services 10.5.4 Financial Overview 10.5.5 SWOT Analysis 10.5.6 Key Developments 10.6 B Braun SE 10.6.1 Key Facts 10.6.2 Business Description 10.6.3 Products and Services 10.6.4 Financial Overview 10.6.5 SWOT Analysis 10.6.6 Key Developments 10.7 Fresenius Kabi AG 10.7.1 Key Facts 10.7.2 Business Description 10.7.3 Products and Services 10.7.4 Financial Overview 10.7.5 SWOT Analysis 10.7.6 Key Developments 10.8 Vifor Pharma Management AG 10.8.1 Key Facts 10.8.2 Business Description 10.8.3 Products and Services 10.8.4 Financial Overview 10.8.5 SWOT Analysis 10.8.6 Key Developments 10.9 Aculife Healthcare Pvt Ltd 10.9.1 Key Facts 10.9.2 Business Description 10.9.3 Products and Services 10.9.4 Financial Overview 10.9.5 SWOT Analysis 10.9.6 Key Developments 11. Appendix 11.1 About The Insight Partners 11.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートThe Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(acid)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/08 10:26 148.90 円 163.91 円 197.75 円 |